A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 mut /CD79B mut diffuse large B-cell lymphoma.
Ting DengShiyuan ZhangMin XiaoJia GuLiang HuangHongping BaPublished in: Cancer medicine (2024)
may benefit from BTKis according to real-world clinical data.